NIH RADx
Overview
NIH RADx is a federal initiative managed by the National Institutes of Health (NIH) that provides grant funding and technical support to accelerate the development, validation, and commercialization of diagnostic technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Javelin Biotech | Jun 2026 | Grant | Co-investor |
| Sysrev | May 2026 | Grant | Lead |
| Eldec Pharmaceuticals | Apr 2026 | Grant | Co-investor |
| SocialRx Inc | Apr 2026 | Grant | Co-investor |
| AivoCode, Inc. | Apr 2026 | Grant | Co-investor |
Key People
Chi-Ping Day
Founder, NIH Interspecific Modeling Interest Group (ISMIG)
Nananda Col
Founder, Shared Decision Making Resources
Bridget Lampert
Managing Director, NIH Oxford Cambridge Scholars Program And MDPhD Program
Kristi M. Porter
Managing Director, NIH Oxford-Cambridge Scholars Program
Kris Walker
Clinical Research Partner
Cari A. Tvinnereim
Director - UX Strategy
Christian Grillon
Principal Investigator
Dan Benjamini
Principal Investigator. Chief, Multiscale Imaging And Integrative Biophysics Unit, NIA
David McDermott
Principal Investigator
Dhruba Chattoraj
Sr. Principal Investigator
Dianne Thorpe
Principal Administrative Officer
Doris Wu
Principal Investigator
Emmanouil Maragkakis
Stadtman Principal Investigator & Chief Of Computational Genomics Unit
Gene Teveler
Principal Enterprise Architect
Ghazala Ashfaq
Principal
Jian Liu
Principal Investigator
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
